Bibliographic Info
GuidelineConsolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
Year of Publication2014
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Moderate
HCV serology testing should be offered to individuals from populations with high HCV prevalence or who have a personal history of HCV risk exposure/behaviour
Notes and Remarks
- 1)New WHO clinical guidance on hepatitis B treatment and screening strategies for hepatitis B and C, have been developed in 2014 and 2015.
- 2)WHO HCV guidelines provide detailed guidance on treatment and care (158).
- 3)There are challenges in diagnosing and treating active HCV infection in certain populations such as people who inject drugs, particularly in settings with limited access to HCV antibody and RNA assays, diagnostic tools for staging of liver disease and HCV therapy. People receiving ART and HCV drugs require close monitoring for possible drug interactions
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations
Year2016
InstitutionWHO
Guideline
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year2021
InstitutionWHO
Guideline
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year2021
InstitutionWHO